← Back to all substances
C

apixaban

139ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

Class: Factor Xa Inhibitor [EPC]

1 INDICATIONS & USAGE Apixaban is a factor Xa inhibitor indicated: to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. ( 1.1 ) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone...

Known as: apixaban
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
62,005
Total in FDA
90%
Serious Reports
121
Fatal Outcomes

Seriousness

Serious
450
Non-Serious
50

Sex Distribution

Male
250
Female
218
Unknown
32

Age Distribution

0-17
2
18-40
4
41-64
41
65-84
258
85+
63
Unknown
132

Outcomes

Recovered/Resolved
236
Recovering/Resolving
103
Not Recovered/Not Resolved
248
Recovered with Sequelae
16
Fatal
121
Unknown
648

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-60ad4f
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...